Seeking Alpha

Raptor Pharmaceutical (RPTP +3.38%) moves higher after saying it's acquired exclusive rights...

Raptor Pharmaceutical (RPTP +3.38%) moves higher after saying it's acquired exclusive rights from McGill University to intellectual property related to a potential malaria treatment. With the patent, the company hopes to capitalize on promising preclinical findings on the use of cysteamine and related compounds for the treatment of malaria.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs